Cynapsus Therapeutics Appoints Tamar Howson To Board Of Directors

TORONTO--(BUSINESS WIRE)--Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson’s disease, today announced that Tamar Howson has been appointed to the Company's Board of Directors. With the addition of Ms. Howson to the Board of Directors, the Company now has eight directors, with seven directors classified as independent.

Help employers find you! Check out all the jobs and post your resume.